The Ebola virus outbreak in West Africa has claimed the life of another health worker.
One of the doctors leading the fight against the disease in Sierra Leone has died after it was decided to not give him an experimental treatment for Ebola because other doctors were afraid it could trigger a dangerous immune response.
This comes as the outbreak has killed more than 1,000 people. Only two Americans an a Spaniard have received the experimental drug so far.
The World Health Organization said it would allow the drug to be used to treat Ebola victims in West Africa on Tuesday.
As the world watches the Ebola outbreak grow, a Cambridge, Massachusetts, based start-up is joining in the fight.
Nanobiosym has created a new medical device that could help detect and stop the spread of the Ebola virus.
"It's important for us to bring the best technologies we have available to any part of the world to help rapidly respond, to enable people out in the field to rapidly respond to detect and contain the spread of the disease," Dr. Anita Goel, founder, chairwoman and CEO of Nanobiosym, said.